Baidu
map

中国疾控中心:新报告老年人艾滋病感染者增长明显

2019-12-02 王秉阳、鲍晓菁、林苗苗 新华社

记者从国家卫健委疾控局了解到,2019年1月至10月全国共检测2.3亿人次,新报告发现艾滋病感染者13.1万例。中国疾病预防控制中心性病艾滋病预防控制中心主任韩孟杰表示,新报告老年人艾滋病感染者增长非常明显。国家卫健委疾控局发布的我国艾滋病防治工作最新进展表明,目前性传播成为主要传播途径。“一些老年人存在易感染艾滋病的危险性行为,没有采取安全措施。不清楚艾滋病风险,或者认为年纪比较大,预防不预防也

记者从国家卫健委疾控局了解到,2019年1月至10月全国共检测2.3亿人次,新报告发现艾滋病感染者13.1万例。中国疾病预防控制中心性病艾滋病预防控制中心主任韩孟杰表示,新报告老年人艾滋病感染者增长非常明显。

国家卫健委疾控局发布的我国艾滋病防治工作最新进展表明,目前性传播成为主要传播途径。“一些老年人存在易感染艾滋病的危险性行为,没有采取安全措施。不清楚艾滋病风险,或者认为年纪比较大,预防不预防也不影响。所以在这方面比较忽视。”韩孟杰说。此外,这些感染者要经过几年时间才发病,导致被动被发现。

“预防艾滋病最简单有效的办法首先是洁身自好,其次就是在性行为时全程使用安全套。拒绝危险性行为,做好自身防护是最有效预防手段。”北京协和医院感染内科主任李太生说。

韩孟杰表示,社会要关注老年人的健康问题,应该采取多部门共同合作方式,加强对老年人宣传教育,比如通过寓教于乐、丰富老年人业余生活,在尊老敬老活动中传递知识,同时对已经感染的老年人给予关怀,使他们及时接受治疗。

今年我国世界艾滋病日宣传活动主题是“社区动员同防艾,健康中国我行动”,强调了包括参与艾滋病防治工作的社会组织、基层医疗卫生机构、居民委员会、村民委员会等社区的优势和作用。“通过社区,可以更好为老年人开展服务,可以利用基本公共卫生服务项目,为老年人提供艾滋病宣传检测服务,更好地发挥作用。”韩孟杰表示,目前报告的感染者中还有约1/3的人发现比较晚,有些感染者已经感染了五六年,不利于疾病防控,要加强艾滋病感染的宣传,主动及时接受检测。

“目前不仅是医疗机构、疾控中心,在部分乡镇社区也有快速检测点。另外还可以在自我检测试剂药店和网上购买,都可以更好接受检测。”北京协和医院感染内科副主任曹玮说。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2048299, encodeId=dae0204829945, content=<a href='/topic/show?id=f8062191152' target=_blank style='color:#2F92EE;'>#中国疾控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21911, encryptionId=f8062191152, topicName=中国疾控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Sun Feb 09 12:25:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811085, encodeId=e22a181108556, content=<a href='/topic/show?id=bf6b8680136' target=_blank style='color:#2F92EE;'>#艾滋病感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86801, encryptionId=bf6b8680136, topicName=艾滋病感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5319428, createdName=jjjiang0199, createdTime=Sun Dec 22 00:25:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405341, encodeId=27df140534159, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Wed Dec 04 07:25:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530249, encodeId=d07e1530249b6, content=<a href='/topic/show?id=5b3d21912a7' target=_blank style='color:#2F92EE;'>#中国疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21912, encryptionId=5b3d21912a7, topicName=中国疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd912073499, createdName=tcm103hq, createdTime=Wed Dec 04 07:25:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376289, encodeId=57963e628961, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:33:25 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376288, encodeId=1f013e6288c7, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:33:23 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376287, encodeId=45c83e628734, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:32:43 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376286, encodeId=ef363e6286db, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:32:38 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2048299, encodeId=dae0204829945, content=<a href='/topic/show?id=f8062191152' target=_blank style='color:#2F92EE;'>#中国疾控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21911, encryptionId=f8062191152, topicName=中国疾控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Sun Feb 09 12:25:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811085, encodeId=e22a181108556, content=<a href='/topic/show?id=bf6b8680136' target=_blank style='color:#2F92EE;'>#艾滋病感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86801, encryptionId=bf6b8680136, topicName=艾滋病感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5319428, createdName=jjjiang0199, createdTime=Sun Dec 22 00:25:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405341, encodeId=27df140534159, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Wed Dec 04 07:25:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530249, encodeId=d07e1530249b6, content=<a href='/topic/show?id=5b3d21912a7' target=_blank style='color:#2F92EE;'>#中国疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21912, encryptionId=5b3d21912a7, topicName=中国疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd912073499, createdName=tcm103hq, createdTime=Wed Dec 04 07:25:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376289, encodeId=57963e628961, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:33:25 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376288, encodeId=1f013e6288c7, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:33:23 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376287, encodeId=45c83e628734, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:32:43 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376286, encodeId=ef363e6286db, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:32:38 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2048299, encodeId=dae0204829945, content=<a href='/topic/show?id=f8062191152' target=_blank style='color:#2F92EE;'>#中国疾控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21911, encryptionId=f8062191152, topicName=中国疾控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Sun Feb 09 12:25:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811085, encodeId=e22a181108556, content=<a href='/topic/show?id=bf6b8680136' target=_blank style='color:#2F92EE;'>#艾滋病感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86801, encryptionId=bf6b8680136, topicName=艾滋病感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5319428, createdName=jjjiang0199, createdTime=Sun Dec 22 00:25:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405341, encodeId=27df140534159, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Wed Dec 04 07:25:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530249, encodeId=d07e1530249b6, content=<a href='/topic/show?id=5b3d21912a7' target=_blank style='color:#2F92EE;'>#中国疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21912, encryptionId=5b3d21912a7, topicName=中国疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd912073499, createdName=tcm103hq, createdTime=Wed Dec 04 07:25:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376289, encodeId=57963e628961, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:33:25 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376288, encodeId=1f013e6288c7, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:33:23 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376287, encodeId=45c83e628734, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:32:43 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376286, encodeId=ef363e6286db, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:32:38 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2048299, encodeId=dae0204829945, content=<a href='/topic/show?id=f8062191152' target=_blank style='color:#2F92EE;'>#中国疾控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21911, encryptionId=f8062191152, topicName=中国疾控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Sun Feb 09 12:25:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811085, encodeId=e22a181108556, content=<a href='/topic/show?id=bf6b8680136' target=_blank style='color:#2F92EE;'>#艾滋病感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86801, encryptionId=bf6b8680136, topicName=艾滋病感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5319428, createdName=jjjiang0199, createdTime=Sun Dec 22 00:25:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405341, encodeId=27df140534159, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Wed Dec 04 07:25:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530249, encodeId=d07e1530249b6, content=<a href='/topic/show?id=5b3d21912a7' target=_blank style='color:#2F92EE;'>#中国疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21912, encryptionId=5b3d21912a7, topicName=中国疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd912073499, createdName=tcm103hq, createdTime=Wed Dec 04 07:25:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376289, encodeId=57963e628961, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:33:25 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376288, encodeId=1f013e6288c7, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:33:23 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376287, encodeId=45c83e628734, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:32:43 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376286, encodeId=ef363e6286db, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:32:38 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2048299, encodeId=dae0204829945, content=<a href='/topic/show?id=f8062191152' target=_blank style='color:#2F92EE;'>#中国疾控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21911, encryptionId=f8062191152, topicName=中国疾控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Sun Feb 09 12:25:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811085, encodeId=e22a181108556, content=<a href='/topic/show?id=bf6b8680136' target=_blank style='color:#2F92EE;'>#艾滋病感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86801, encryptionId=bf6b8680136, topicName=艾滋病感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5319428, createdName=jjjiang0199, createdTime=Sun Dec 22 00:25:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405341, encodeId=27df140534159, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Wed Dec 04 07:25:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530249, encodeId=d07e1530249b6, content=<a href='/topic/show?id=5b3d21912a7' target=_blank style='color:#2F92EE;'>#中国疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21912, encryptionId=5b3d21912a7, topicName=中国疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd912073499, createdName=tcm103hq, createdTime=Wed Dec 04 07:25:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376289, encodeId=57963e628961, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:33:25 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376288, encodeId=1f013e6288c7, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:33:23 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376287, encodeId=45c83e628734, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:32:43 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376286, encodeId=ef363e6286db, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:32:38 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
    2019-12-02 14794e5bm67(暂无昵称)

    学习了,谢谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2048299, encodeId=dae0204829945, content=<a href='/topic/show?id=f8062191152' target=_blank style='color:#2F92EE;'>#中国疾控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21911, encryptionId=f8062191152, topicName=中国疾控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Sun Feb 09 12:25:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811085, encodeId=e22a181108556, content=<a href='/topic/show?id=bf6b8680136' target=_blank style='color:#2F92EE;'>#艾滋病感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86801, encryptionId=bf6b8680136, topicName=艾滋病感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5319428, createdName=jjjiang0199, createdTime=Sun Dec 22 00:25:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405341, encodeId=27df140534159, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Wed Dec 04 07:25:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530249, encodeId=d07e1530249b6, content=<a href='/topic/show?id=5b3d21912a7' target=_blank style='color:#2F92EE;'>#中国疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21912, encryptionId=5b3d21912a7, topicName=中国疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd912073499, createdName=tcm103hq, createdTime=Wed Dec 04 07:25:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376289, encodeId=57963e628961, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:33:25 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376288, encodeId=1f013e6288c7, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:33:23 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376287, encodeId=45c83e628734, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:32:43 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376286, encodeId=ef363e6286db, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:32:38 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
    2019-12-02 14794e5bm67(暂无昵称)

    学习了,谢谢分享

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2048299, encodeId=dae0204829945, content=<a href='/topic/show?id=f8062191152' target=_blank style='color:#2F92EE;'>#中国疾控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21911, encryptionId=f8062191152, topicName=中国疾控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Sun Feb 09 12:25:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811085, encodeId=e22a181108556, content=<a href='/topic/show?id=bf6b8680136' target=_blank style='color:#2F92EE;'>#艾滋病感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86801, encryptionId=bf6b8680136, topicName=艾滋病感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5319428, createdName=jjjiang0199, createdTime=Sun Dec 22 00:25:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405341, encodeId=27df140534159, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Wed Dec 04 07:25:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530249, encodeId=d07e1530249b6, content=<a href='/topic/show?id=5b3d21912a7' target=_blank style='color:#2F92EE;'>#中国疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21912, encryptionId=5b3d21912a7, topicName=中国疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd912073499, createdName=tcm103hq, createdTime=Wed Dec 04 07:25:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376289, encodeId=57963e628961, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:33:25 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376288, encodeId=1f013e6288c7, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:33:23 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376287, encodeId=45c83e628734, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:32:43 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376286, encodeId=ef363e6286db, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:32:38 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
    2019-12-02 14794e5bm67(暂无昵称)

    学习了,谢谢分享

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2048299, encodeId=dae0204829945, content=<a href='/topic/show?id=f8062191152' target=_blank style='color:#2F92EE;'>#中国疾控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21911, encryptionId=f8062191152, topicName=中国疾控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Sun Feb 09 12:25:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811085, encodeId=e22a181108556, content=<a href='/topic/show?id=bf6b8680136' target=_blank style='color:#2F92EE;'>#艾滋病感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86801, encryptionId=bf6b8680136, topicName=艾滋病感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5319428, createdName=jjjiang0199, createdTime=Sun Dec 22 00:25:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405341, encodeId=27df140534159, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Wed Dec 04 07:25:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530249, encodeId=d07e1530249b6, content=<a href='/topic/show?id=5b3d21912a7' target=_blank style='color:#2F92EE;'>#中国疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21912, encryptionId=5b3d21912a7, topicName=中国疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd912073499, createdName=tcm103hq, createdTime=Wed Dec 04 07:25:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376289, encodeId=57963e628961, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:33:25 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376288, encodeId=1f013e6288c7, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:33:23 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376287, encodeId=45c83e628734, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:32:43 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376286, encodeId=ef363e6286db, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 19:32:38 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
    2019-12-02 14794e5bm67(暂无昵称)

    学习了,谢谢分享

    0

相关资讯

Scientific Reports:生男生女大不同 高龄孕妇男性后代心血管疾病风险明显增高

近日,一项刊登于Nature子刊Scientific Reports的新研究关于高龄孕妇又有了新见解,动物实验研究发现,大龄孕鼠的胎盘功能会发生改变,这种改变将导致男性后代健康状况恶化的风险升高,尤其在心血管疾病方面,而对女性后代则无明显影响。为什么会有这种性别差异呢?胎盘功能变化又是如何影响胎儿健康的呢?胎盘将营养和氧气从母体输送到胎儿,并向母体分泌信号因子。所以她支持胎儿发育,并且是胎儿对母体

“平安好医生”人为刷单,用意何在?是偶然还是有组织的常态?

最近,平安好医生手机APP上的健康商城内,自营店在销售一款纸尿裤和一款奶瓶时,存在人为“刷单”的行为。该行为被视为“弄虚作假”,欺骗消费者,被市场监管局行政处罚。被处罚的是平安健康互联网股份有限公司上海分公司,是平安健康互联网股份有限公司设立的子公司,也是平安好医生手机APP的运营主体。今年5月4日,该公司把一款“Insoftb/婴舒宝纸尿裤”的单品价格从29.9元改为1元,该公司员工以平台用户的

我国研制出增强抗癌疗效的“智能光热材料”

中国科学技术大学梁高林教授课题组近期研制出一种新材料,相比目前临床常用的光热材料,其光热转换效率提升一倍以上,在光热抗癌技术领域实现了重要突破。国际材料领域顶级学术期刊《先进功能材料》日前发表了该成果。光热疗法是继手术、化疗、放疗之后兴起的一种新型微创抗癌技术,其技术原理是将具有光热转换功能的药材注入人体,运用靶向识别技术将其聚集在肿瘤附近,再通过激光照射将光能转化为热能杀死癌细胞。但是,当激光照

饶毅实名举报论文造假 波及阿尔兹海默症新药企业

首都医科大学校长饶毅实名举报论文造假今日被刷屏。据网传截图显示,饶毅向国家自然科学基金委实名举报三例学术不端行为,其中包括上海药物所耿美玉研究员论文造假。而11月2日获有条件上市批准的治疗阿尔茨海默病新药甘露特钠胶囊(商品名:九期一,代号:GV-971),正是据称由中国科学院上海药物研究所耿美玉研究员领导研究团队,坚持22年,在中国海洋大学、中国科学院上海药物研究所与绿谷制药接续努力研发成功的原创

“国家护理质量数据平台”如何建设、应用及改进?

【摘要】为实现在统一的指标体系指引下,用统一的标准、规则采集各医疗机构碎片化护理质量数据并进行整合利用,建立了“国家护理质量数据平台”。平台主要功能有数据采集、分析、反馈、管理及资源共享。经平台运行与应用后,截止2017年底,各类护理质量指标数据的年度填报完整率均超过98%;截止2018年11月,平台拥有用户1 829家。针对平台存在的不足,建议探索平台技术升级,拓展平台功能,以期为医院、行业

国家医保局定调,体外诊断行业变革来了

框架形成,推进新政策近日,国家医保局回复了全国人大代表的提案,从内容中可以看到,体外诊断行业将继续迎来变革。回复中指出,国家医保局将加大改革力度,重点推进按病种、按疾病诊断相关分组(DRG)等支付方式。目前,全国各地普遍制定与不同医疗服务形式相适应的医保支付方式改革政策,不断完善与公立医院改革等医改措施相配套的管理措施,总额预算管理下的多元复合式付费框架基本形成,部分地区正在积极探索DRG付费工作

Baidu
map
Baidu
map
Baidu
map